Article Versions Notes

Kuo T-T, Chen Y-H, Wang V, Huang EY-K, Ma K-H, Greig NH, Jung J, Choi H-I, Olson L, Hoffer BJ, et al. PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences. 2023; 24(5):4687. https://doi.org/10.3390/ijms24054687

Kuo, Tung-Tai, Yuan-Hao Chen, Vicki Wang, Eagle Yi-Kung Huang, Kuo-Hsing Ma, Nigel H. Greig, Jin Jung, Ho-II Choi, Lars Olson, Barry J. Hoffer, and et al. 2023. "PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease" International Journal of Molecular Sciences 24, no. 5: 4687. https://doi.org/10.3390/ijms24054687

Kuo, T.-T., Chen, Y.-H., Wang, V., Huang, E. Y.-K., Ma, K.-H., Greig, N. H., Jung, J., Choi, H.-I., Olson, L., Hoffer, B. J., & Tseng, K.-Y. (2023). PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences, 24(5), 4687. https://doi.org/10.3390/ijms24054687